Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Read

Showing results (681-690 of 718) with videos related to

Pageof 72
Sort By:
Chemmedchem|June 13, 2019
Substituted Aminoacetamides as Novel Leads for Malaria TreatmentNeil R Norcross, Caroline Wilson, Beatriz Baragaña, et al.
European Journal of Medicinal Chemistry|July 1, 2025
Targeting dihydroorotate dehydrogenase (DHODH) for host-directed therapy: Discovery of a novel alkyne-based scaffold inhibitor effective against SARS-CoV-2Miguel M Vaidergorn, Aline D Purificação, Pedro I P Leite, et al.
Journal of Medicinal Chemistry|August 1, 2025
Design and Development of Lysyl tRNA Synthetase Inhibitors, for the Treatment of TuberculosisSusan H Davis, Michael Mathieson, Kirsteen I Buchanan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2026
Use of a cytochrome P450 humanized mouse model to refine schistosomiasis drug discoverySarah D Davey, Josephine E Forde-Thomas, Benjamin J Hulme, et al.
Nature|April 3, 2010
N-myristoyltransferase inhibitors as new leads to treat sleeping sicknessJulie A Frearson, Stephen Brand, Stuart P McElroy, et al.
Ecology and Evolution|October 20, 2022
Integrating natural gradients, experiments, and statistical modeling in a distributed network experiment: An example from the WaRM NetworkCase M Prager, Aimee T Classen, Maja K Sundqvist, et al.
Science Translational Medicine|December 13, 2023
Short-course combination treatment for experimental chronic Chagas diseaseSilvia González, Richard J Wall, John Thomas, et al.
Science Translational Medicine|October 23, 2024
<i>Cryptosporidium</i> lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacyNicola Caldwell, Caroline Peet, Peter Miller, et al.
Analytica Chimica Acta|November 29, 2020
Development of a reference material for analysing naturally occurring radioactive material from the steel industryE Braysher, B Russell, S M Collins, et al.
Journal of Medicinal Chemistry|June 18, 2016
Trisubstituted Pyrimidines as Efficacious and Fast-Acting AntimalarialsNeil R Norcross, Beatriz Baragaña, Caroline Wilson, et al.
Pageof 72

Showing results (681-690 of 718) with videos related to

Sort By:
Pageof 72
Chemmedchem|June 13, 2019
Substituted Aminoacetamides as Novel Leads for Malaria TreatmentNeil R Norcross, Caroline Wilson, Beatriz Baragaña, et al.
European Journal of Medicinal Chemistry|July 1, 2025
Targeting dihydroorotate dehydrogenase (DHODH) for host-directed therapy: Discovery of a novel alkyne-based scaffold inhibitor effective against SARS-CoV-2Miguel M Vaidergorn, Aline D Purificação, Pedro I P Leite, et al.
Journal of Medicinal Chemistry|August 1, 2025
Design and Development of Lysyl tRNA Synthetase Inhibitors, for the Treatment of TuberculosisSusan H Davis, Michael Mathieson, Kirsteen I Buchanan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2026
Use of a cytochrome P450 humanized mouse model to refine schistosomiasis drug discoverySarah D Davey, Josephine E Forde-Thomas, Benjamin J Hulme, et al.
Nature|April 3, 2010
N-myristoyltransferase inhibitors as new leads to treat sleeping sicknessJulie A Frearson, Stephen Brand, Stuart P McElroy, et al.
Ecology and Evolution|October 20, 2022
Integrating natural gradients, experiments, and statistical modeling in a distributed network experiment: An example from the WaRM NetworkCase M Prager, Aimee T Classen, Maja K Sundqvist, et al.
Science Translational Medicine|December 13, 2023
Short-course combination treatment for experimental chronic Chagas diseaseSilvia González, Richard J Wall, John Thomas, et al.
Science Translational Medicine|October 23, 2024
<i>Cryptosporidium</i> lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacyNicola Caldwell, Caroline Peet, Peter Miller, et al.
Analytica Chimica Acta|November 29, 2020
Development of a reference material for analysing naturally occurring radioactive material from the steel industryE Braysher, B Russell, S M Collins, et al.
Journal of Medicinal Chemistry|June 18, 2016
Trisubstituted Pyrimidines as Efficacious and Fast-Acting AntimalarialsNeil R Norcross, Beatriz Baragaña, Caroline Wilson, et al.
Pageof 72